Logo image
Autoimmune inner ear disease in children
Journal article   Peer reviewed

Autoimmune inner ear disease in children

Natalie C Huang and Robert T Sataloff
Otology & neurotology, v 32(2)
Feb 2011
PMID: 21178803

Abstract

Adolescent Anti-Inflammatory Agents - therapeutic use Antimetabolites, Antineoplastic - therapeutic use Antineoplastic Agents - therapeutic use Antineoplastic Agents, Alkylating - therapeutic use Auditory Threshold Autoimmune Diseases - immunology Blotting, Western Bone Conduction Child Child, Preschool Cyclophosphamide - therapeutic use Female Hearing Loss, Sensorineural - immunology Hematologic Tests HLA-DR4 Antigen - immunology Humans Labyrinth Diseases - immunology Male Methotrexate - therapeutic use Prednisone - therapeutic use Retrospective Studies Speech Perception Steroids - therapeutic use
To determine the response to treatment of pediatric patients diagnosed with autoimmune inner ear disease. Seven children who presented with sensorineural hearing loss and were diagnosed with autoimmune inner ear disease. Diagnosis through blood testing. Treatment with steroids and/or cytotoxic medication. Improvement in pure-tone average and speech discrimination scores on audiometric testing. Six of the 7 children (85.7%) improved with treatment, and the remaining patient had no measurable progression of disease. Children with autoimmune inner ear disease seem to benefit from treatment with steroids and/or cytotoxic medication. Although such medications must be used with caution in the pediatric population, they should not be withheld simply because of young age.

Metrics

6 Record Views
13 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Clinical Neurology
Otorhinolaryngology
Logo image